204 related articles for article (PubMed ID: 1394218)
1. Cytotoxicity of CD3-ricin A chain immunotoxins in relation to cellular uptake and degradation kinetics.
van Oosterhout YV; Preijers FW; Wessels HM; de Witte T
Cancer Res; 1992 Nov; 52(21):5921-5. PubMed ID: 1394218
[TBL] [Abstract][Full Text] [Related]
2. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
Kornfeld SB; Leonard JE; Mullen MD; Taetle R
Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo enhancement of ricin-A chain immunotoxin activity by novel indolizine calcium channel blockers: delayed intracellular degradation linked to lipidosis induction.
Jaffrézou JP; Levade T; Thurneyssen O; Chiron M; Bordier C; Attal M; Chatelain P; Laurent G
Cancer Res; 1992 Mar; 52(5):1352-9. PubMed ID: 1737397
[TBL] [Abstract][Full Text] [Related]
4. Endocytosis of an antibody ricin A-chain conjugate (immuno-A-toxin) adsorbed on colloidal gold. Effects of ammonium chloride and monensin.
Carrière D; Casellas P; Richer G; Gros P; Jansen FK
Exp Cell Res; 1985 Feb; 156(2):327-40. PubMed ID: 2857124
[TBL] [Abstract][Full Text] [Related]
5. Endocytosis of immunotoxin-791T/36-RTA by tumor cells in relation to its cytotoxic action.
Byers VS; Pawluczyk IZ; Hooi DS; Price MR; Carroll S; Embleton MJ; Garnett MC; Berry N; Robins RA; Baldwin RW
Cancer Res; 1991 Apr; 51(8):1990-5. PubMed ID: 2009518
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of the cytotoxicity of liposomal ricin by the carboxylic ionophore monensin and the lysosomotropic amine NH4Cl in Chinese hamster ovary cells.
Bharadwaj S; Rathore SS; Ghosh PC
Int J Toxicol; 2006; 25(5):349-59. PubMed ID: 16940007
[TBL] [Abstract][Full Text] [Related]
7. Internalization of the cytotoxic molecules of T101 F(ab')2-(ricin-A-chain) immunotoxin into human T-leukemic cells.
Ravel S; Casellas P
Eur J Biochem; 1990 Sep; 192(2):469-73. PubMed ID: 2209602
[TBL] [Abstract][Full Text] [Related]
8. Recombinant ricin A chain conjugated to monoclonal antibodies: improved tumor cell inhibition in the presence of lysosomotropic compounds.
Ramakrishnan S; Bjorn MJ; Houston LL
Cancer Res; 1989 Feb; 49(3):613-7. PubMed ID: 2783383
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic potency of CD22-ricin A depends on intracellular routing rather than on the number of internalized molecules.
van Horssen PJ; van Oosterhout YV; de Witte T; Preijers FW
Scand J Immunol; 1995 Jun; 41(6):563-9. PubMed ID: 7770726
[TBL] [Abstract][Full Text] [Related]
10. Characterization of two distinct pathways of endocytosis of ricin by rat liver endothelial cells.
Magnusson S; Kjeken R; Berg T
Exp Cell Res; 1993 Mar; 205(1):118-25. PubMed ID: 8453986
[TBL] [Abstract][Full Text] [Related]
11. Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins.
van Oosterhout YV; van den Herik-Oudijk IE; Wessels HM; de Witte T; van de Winkel JG; Preijers FW
Cancer Res; 1994 Jul; 54(13):3527-32. PubMed ID: 7516821
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
Calvete JA; Newell DR; Wright AF; Rose MS
Cancer Res; 1994 Sep; 54(17):4684-90. PubMed ID: 8062265
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of ricin A chain immunotoxin activity by perhexiline on established and fresh leukemic cells.
Jaffrézou JP; Levade T; Kuhlein E; Thurneyssen O; Chiron M; Grandjean H; Carrière D; Laurent G
Cancer Res; 1990 Sep; 50(17):5558-66. PubMed ID: 2386962
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody-ricin A chain conjugate selectively cytotoxic for cells bearing the common acute lymphoblastic leukemia antigen.
Raso V; Ritz J; Basala M; Schlossman SF
Cancer Res; 1982 Feb; 42(2):457-64. PubMed ID: 6948605
[TBL] [Abstract][Full Text] [Related]
15. In vitro cytotoxicity of recombinant ricin A chain-antitransferrin receptor immunotoxin against human adenocarcinomas of the colon and pancreas.
Griffin TW; Pagnini PG; McGrath JJ; McCann JC; Houston LL
J Biol Response Mod; 1988 Dec; 7(6):559-67. PubMed ID: 3265147
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of the specific cytotoxicity of a breast cancer-associated antigen immunotoxin by the carboxylic ionophore monensin.
Griffin TW; Pagnini PG; Houston LL
J Biol Response Mod; 1987 Oct; 6(5):537-45. PubMed ID: 3500277
[TBL] [Abstract][Full Text] [Related]
17. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
Griffin T; Raso V
Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
[TBL] [Abstract][Full Text] [Related]
18. Sensitivity of human leukemia cells in exponential or stationary growth phase to anti-CD5 immunotoxins. Role of intracellular processing events.
Chignola R; Anselmi C; Franceschi A; Pasti M; Candiani C; Tridente G; Colombatti M
J Immunol; 1994 Mar; 152(5):2333-43. PubMed ID: 7510743
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
Masui H; Kamrath H; Apell G; Houston LL; Mendelsohn J
Cancer Res; 1989 Jul; 49(13):3482-8. PubMed ID: 2786451
[TBL] [Abstract][Full Text] [Related]
20. Selective killing of human T-lymphotropic virus-I infected leukemic T-cells by monoclonal anti-interleukin 2 receptor antibody-ricin A chain conjugates: potentiation by ammonium chloride and monensin.
Krönke M; Schlick E; Waldmann TA; Vitetta ES; Greene WC
Cancer Res; 1986 Jul; 46(7):3295-8. PubMed ID: 3011246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
